help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pettibone, D. J.
Right arrow Articles by Hensens, O. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pettibone, D. J.
Right arrow Articles by Hensens, O. D.

Endocrinology, Vol 125, 217-222, Copyright © 1989 by Endocrine Society

ARTICLES

A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensis

DJ Pettibone, BV Clineschmidt, PS Anderson, RM Freidinger, GF Lundell, LR Koupal, CD Schwartz, JM Williamson, MA Goetz and OD Hensens
Department of New Lead Pharmacology, Merck, Sharp, and Dohme Research Laboratories, West Point, Pennsylvania 19486.

The in vitro and in vivo oxytocin/arginine vasopressin (OT/AVP) antagonist properties of two cyclic hexapeptides derived from a newly discovered natural product (L-156,373) of Streptomyces silvensis are described. In radioligand binding assays, L-156,373 [cyclo(L-Pro-D-Phe- N-OH-L-Ile-D-piperazyl-L-piperazyl-N-Me-D -Phe)] exhibited moderate affinity for rat uterine OT receptors (Ki, 150 nM), with some selectivity (approximately 20-fold) vs. liver AVP-V1 and kidney AVP-V2 receptors. Dehydroxylation of N-hydroxyisoleucine and oxidation of the piperazic acid residues of L-156-373 produced an interesting derivative, L-365,209. These structural modifications increased OT receptor affinity and selectivity by 20- and 2.5-5-fold, respectively. In the isolated rat uterus, L-365,209 was a potent (apparent dissociation constant, 1.7 nM) and competitive OT antagonist. L-365,209 also blocked the effects of AVP at both AVP-V1 (phosphatidylinositol turnover in rat hepatocytes) and AVP-V2 (adenylate cyclase in rat kidney medulla) receptors, but only at low micromolar concentrations. L- 365,209, given iv to anesthetized rats, antagonized the action of exogenous OT on the uterus (ID50, 460 micrograms/kg) with a relatively long duration of action. L-365,209 represents a unique class of compounds that provides an entirely new approach for the design of antagonists for these neurohypophyseal hormones.


This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
B. F. Mitchell and B. Schmid
Oxytocin and its Receptor in the Process of Parturition
Reproductive Sciences, May 1, 2001; 8(3): 122 - 133.
[Abstract] [PDF]

Home page
 Reproductive SciencesHome page
M. D. Fejgin, S. C. Pak, G. Flouret, M. T. Parsons, and L. Wilson Jr
Comparison of the In Vivo Activity of Different Oxytocin Antagonists in the Pregnant Baboon
Reproductive Sciences, September 1, 1998; 5(5): 251 - 254.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society